Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma vs. control in treatment of COVID-19
IRCT20120215009014N353Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 2, randomised trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hamadan University of Medical Sciences. Started May 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20120215009014N353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N353.